Announced
Completed
Financials
Sources
Tags
drug discovery platform
Venture Capital
France
Minority
Completed
Private
Pharmaceuticals
Domestic
Acquisition
Private Equity
Friendly
Synopsis
Eurazeo, an investment company, and Bpifrance, a French investment firm, led a €30m Series A funding round in Aqemia, a developer of a drug discovery platform, with participation from Elaia. “After repeated successes in generating very efficiently innovative new chemical matter in collaboration with large pharmaceutical companies around the world, we are now excited to leverage this fundraising to accelerate towards Aqemia’s mission: build a massive pipeline of wholly-owned drug discovery projects," Maximilien Levesque, Aqemia Co-Founder and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.